A portfolio of ventures operating at the intersection of human performance, technology, and biological innovation.
The most important problems sit at borders — between biology and technology, between science and commerce, between what humans are and what they could be. We don't pick a lane. We build at the intersection.
Annabelle operates at the rarest intersection: deep bench science and commercial instinct. From stem cell research at Imperial to strategy at HEC Paris, she built Rift Labs to close the gap between what the lab discovers and what the market actually needs.
Tamas builds things that shouldn't exist yet. With an MBA from Imperial and a background spanning portfolio management at an FMCG multi and entrepreneurship, he brings the structural thinking that turns a compelling idea into a defensible business.